Development and evaluation of a mobile health intervention for CO-morbid opioid use disorder and posttraumatic stress disorder during community RE-entry

Ended Project Grant Awarded Last action

Award ID
R61DA061335
Recipient
Awarding agency
Obligated
$2,729,018

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date
Place of performance
Kingston, RI 02881, USA

Award details come from USAspending.gov.

About this award

The National Institute on Drug Abuse (NIDA) awarded a $2,729,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Rhode Island. The purpose of this 2-year award, with a start date of September 15, 2024, is to rigorously develop and evaluate a mobile health intervention for adults with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment.

The proposed mobile app will provide 24/7 on-demand resources and automated skills-based interventions to reduce opioid use and related harms. The project will use ecological momentary assessment to identify high-risk states for opioid use and optimize a just-in-time adaptive intervention component. A hybrid experimental design, including a micro-randomized trial and a randomized controlled trial, will evaluate the efficacy of the mobile app compared to treatment-as-usual. The University of Rhode Island has sub-awarded a portion of the grant funding to The Providence Center, Inc., a non-profit organization that will contribute its expertise in behavioral health services and community-based support programs.

Description

Abstract
Of the nearly 400,000 people with an opioid use disorder (OUD) who receive OUD treatment each year, 1 in 6 utilize residential services. Community RE-entry after residential OUD treatment is an especially vulnerable time, with most people who return to use doing so in the 30 days following discharge. Posttraumatic stress disorder (PTSD) is highly prevalent (>50%) among people in residential OUD treatment and linked to worse opioid outcomes following treatment, including return to use during community RE-entry. However, while PTSD treatment access high-risk the they access individual is safe/acceptable/efficacious for people with OUD, return to use after residential OUD treatment happens so quickly, IT is critical that patients have to empirically-supported tools that deliver ongoing upport and resources for PTSD-OUD during this transitional period. Rigorously-developed mobile ealth interventions that adapt provision of care to individual offer a promising and innovative approach to continuing care after residential OUD treatment: can be easily disseminated O people from a wide demographic (high scalability), ensuring equitable to OUD care for our most marginalized populations; overcome many of the structural, social, and barriers to traditional treatment; are cost-effective and sustainable; and provide personalized 24/7 OUD programs rarely provide PTSD treatment. Because S H T care to people at their moments of greatest need while maintaining standardization and fidelity of treatment. The proposed study will use a ground-up approach to rigorously develop and evaluate a mobile APP with both on-demand (24/7 PTSD-OUD resources) and automated (skills-based PTSD-OUD interventions) features to reduce opioid use/harms during community RE-entry of adults with CO-morbid PTSD-OUD. Aim 1 will use ecological momentary assessment (EMA) to identify tailoring of aim variables (i.e., states of high risk for occurrence opioid use and related harms) for a just-in-time adaptive intervention (JITAI) component of the mobile APP. 2 will experimental design to ruse a hybrid igorously develop and evaluate the mobile APP. Specifically, microrandomized trial (MRT) will evaluate the efficacyof intervention options (JITAI) VS. Generic reminders to access resources on the proximal occurrence of opioid use and harms, including optimization of decision rules (e.g., when, whether) to alter dosage, type, and timing of JITAI intervention option delivery, and controlled secondary our final community such randomized trail (RCT) will provide an initia L test of efficacy (primary outcomes: R eturn to opioid use and harms; outcome: PTSD severity) and implementation outcomes of mobile APP VS. Treatment-as-usual. Product will be a highly scalable mobile APP that provides access to 24/7 continuing care during RE-entry (on-demand resources), including in xact moments of need (skills-based interventions). A clinical tool has strong potential to improve health and quality of life for individuals with PTSD-OUD. E

Transactions

Action Obligated Date
Amendment $0
Amendment $1,364,509
Original award $1,364,509

Subawards

Subrecipient Amount Awarded
The Providence Center, Inc. Development and Evaluation of a Mobile Health Intervention for Co-Morbid Opioid Use Disorder and Posttraumatic Stress Disorder During Community Re-entry $122,967
Rhode Island Hospital Development and Evaluation of a Mobile Health Intervention for Co-Morbid Opioid Use Disorder and Posttraumatic Stress disorder during community retry $168,120

Quick answers

Who received award R61DA061335?

R61DA061335 was awarded to University Of Rhode Island by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2024.

How much is award R61DA061335 worth?

$2,729,018 has been obligated on R61DA061335.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award